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SKYIAB MEDICAL EXPERIMENTS PROGRAM

Rufus R. Hessberg, M.D.
Director, Space Medicine
NASA Office of Life Sciences
Headquarters National Aeronautics &
Space Administration
Washington, DC 205*16

ABSTRACT

I will briefly describe the findings associated with each of these areas, of the hardware
developed to support the experiments associated, and describe the procedures and significance of the medical investigations associated
with each. It is important to recognize that
all of the findings on observed changes in
manned space flight to date have been reversible and have returned to the preflight
values for each individual during the postflight observation period.

With the completion of the historic Apollo
Program, the significant medical findings will
be reviewed and the medical results summarized.
The medical objectives of Sky lab will be presented. The medical experiments which will
be conducted and their relationship to the
Apollo medical findings and Skylab objectives
will be discussed. The interrelationship of
the Sky lab medical experiments will be
described and the anticipated information to
be obtained will be postulated.
INTRODUCTION

METABOLISM (Figure 2)

Today we stand on the threshold of a new era
in the United States Manned Space Flight
Program. Mercury, Gemini and Apollo led the
way by establishing unequivocably that man
can effectively perform operational and
applied missions in space flight. The new
era in which we are about to embark next
month will capitalize on all that we have
learned and will, for the first time, emphasize scientific investigations rather than
operations and applications. The Skylab Program
has maintained throughout its design and development, its basic objective to provide an
orbiting laboratory capability and my remarks
will be devoted to the importance of this
program to the Life Sciences. The contribution the medical experiments will provide to
i
the further understanding of some of the
physiological adaptative processes and mechanisms involved in the observed changes in
our manned space flights to date will be discussed. Time will not permit covering the
entire Life Sciences Experiments Program in
Skylab. This paper will be limited to the
medical experiments.

This is more specifically referred to as
nutritional and musculoskeletal function
because ve are interested in the basic metabolic processes of man as they are influenced
by the space flight environment. The most
significant finding, to date, has been the
consistent weight loss experienced by every
astronaut during a mission. We have had one
exception; Al Shepard in Apollo 1^. Most
of the weight loss has been attributed to
loss of body fluid although a small percent
has been lean body mass. There has been indirect evidence of either loss or shift of
body calcium or perhaps both. Attempts to
determine changes in bone density from preto postflight have not been consistent in
verifying total loss of body calcium as
opposed to the alternate theory of calcium
shift. It may be that the manned space
flights to date have been too short to establish the true picture associated with calcium
metabolism and the musculoskeletal system.
Electrolyte changes have occurred and are
most likely associated with the loss of body
fluid.
An example of the difficulty in establishing
specific and consistent findings is the
potassium studies associated with Apollo 15
and 16. In Apollo 15, we used K*2 which is
a method for determining total body exchangeable potassium. At the post flight determination, it was found that the two astronauts

OF MAJOR MEDICAL OBSERVATIONS
As a result of the Mercury, Gemini and Apollo
manned space flights, certain findings have
resulted and can be described in six major
areas of human systems (Figure l) .
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PEMATOLOGT AMD IMMUNOLOGY- (Figure 6)

who had been to the lunar surface had a 15$
decrement from their preflight value obtained
at F minus 5. The Command Module Pilot had a
10$ decrement. During the interval between
Apollo 15 and l6, changes to the diet by
selecting foods high in potassium and fortifying some of the beverages using a potassium
supplement were instituted. In addition,
special attention was paid to the timeline
with emphasis on adequate rest periods and
planning no excessive work days. The Apollo
l6 crew showed no significant change in their
potassium levels postflight. One cannot
attribute this result just to the change in
potassium intake but it certainly points up
the relationship of the nutritional aspect in
terms of maintaining an adequate balance of
basic constituents associated with metabolic
activities. Generally speaking, the changes
observed in this area returned to preflight
control levels from three to five days after
recovery.

In Gemini and Apollo, we have measured the
loss of red cell mass in those flights where
oxygen partial pressures have predominated.
In those Apollo missions which had no cabin
decompression for EVA or where it was postulated that a small percentage of nitrogen
remained in the Command Module atmosphere, we
saw no loss of red cell mass. This poses a
very interesting and intriguing physiological
question which remains unanswered to date,
namely; is it the high oxygen environment
that causes the loss of red cell mass or is
it the presence of nitrogen that prevents the
loss of red cell mass? In addition to the
above, decreased plasma volumes have been
consistently observed postflight and are most
likely associated with the fluid balance
changes and loss of total body water. We
have found immunological changes whose magnitude is in keeping with the changes associated with those observed in ground-based
studies and cannot be attributed exclusively
to space flight. Specifically, we have seen
changes in immune globulins A and G but these
increases were associated with pre- and inflight illness and were within the ranges
associated with such conditions. The increase
in haptoglobin and ceruloplasmin postflight
can be attributed to the stresses of reentry,
splashdown and.recovery.

In Skylab, we plan a comprehensive controlled
metabolic balance study which will provide
data on the inflight status of fluid, electrolyte and hormonal changes coupled with preand postflight data on skeletal and muscle
mass changes. The Skylab crews will commence
this experiment 21 days preflight by going on
the Skylab diet exclusively, to insure a
nutritionally stabilized situation at launch.
They will stay on this for 18 days after
recovery while the postflight investigations
are completed. Precise measurement of the
nutritional constituents will be maintained
throughout the entire period from 21 days
preflight through 18 days postflight. All
food and fluid intake and output will be
measured during this entire period. Unconsuraed portions of food inflight will be measured by the Small Mass Measurement Device
(Figure 3)

In addition to the pre- and postflight Hematology and Immunology Studies, blood will be
drawn inflight for the first time in the U.S.
Manned Space Flight Program and will be
preserved and returned for postflight analysis
for comparison with the pre- and postflight
studies (Figure 7) The information obtained
will augment the body fluid shift studies,
supplement the electrolyte investigations and
provide cross-checks for the metabolic and
cardiovascular experiments.

Inflight, we will be obtaining a 120 cc
sample of urine from each crewman each day
from their 2k hour output. This along with
all feces, which will be dried and returned
with the urine, will be analyzed postflight
(Figure k) . Daily mass measurement will be
obtained inflight using the Whole Body Mass
Measurement Device pictured in Figure 5.
This inflight capability will permit the first
indepth study of the metabolic functions
associated with man and his activities in the
space flight environment. It is anticipated
that we will have a better understanding of
fluid balance mechanisms as a function of
time inflight with the associated electrolyte
and hormonal data. It is anticipated that
more definitive information on calcium, bone
and muscle mass changes will be obtained.

CARDIOVASCULAR (Figure 8)
We have consistently observed throughout
Mercury, Gemini and Apollo, a decreased
orthostatic tolerance postflight. This is a
finding which is readily explained by the
fact that inflight, the cardiovascular system
does not have to work against a gravitational
workload represented by a column of blood
between the feet and heart and between the
heart and the head. Because there are receptors or sensors in the cardiovascular system
called gravi-receptors, they respond to the
weightless environment resulting in a new
physiological level of activity as a normal
adaptative response. The orthostatic
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intolerance observed postflight is a reflection of the changes that occur in space and
are normal for the weightless environment, but
are not adequate for the 1-G environment
until a readaptation back to the preflight
1-G status occurs. In all but Apollo 15, the
return to preflight values have occurred in
three to five days.

energy expenditure for lunar surface EVA's has
been less than predicted. In spite of the
fact that we anticipated a reduced energy
requirement in the 1/6 G environment and we
had obtained metabolic data during 1/6 G simulations, the total expenditure on all lunar
surface EVA's still fell under the predicted
values.

The assessment of the cardiovascular system
is accomplished by imposing an externally
imposed workload or stress on the system. In
the early days of Mercury and Gemini, we
used the tilt table as the stressor but with
subsequent development, the Lower Body Negative Pressure Device (LBNP) has been crosscalibrated with the tilt table and has been
used pre- and postflight in Apollo with the
exception of the quarantine missions (Figure
9). This device will be used inflight in
Skylab and its development was specifically
in anticipation of the inflict ability to
stresses in the cardiovascular system since
it is obvious that the tilt table could only
be used in a gravitational field. By
applying controlled negative pressure to the
lower half of the body at 30, HO and 50 mm Hg
negative pressure, the resultant effect is
that of providing an external force which
tends to "pool" the blood in the lower extremities, thereby, creating a provocative stress
on the cardiovascular system. By using the
vectorcardiogram in conjunction with this
experiment, we will obtain both changes in
heart rate and changes if they occur in the
three dimensional electrical characterization
of the heart. In addition, blood pressure
is obtained every 30 seconds during the use
of the LBNP. This infligit information will
be of inestimable value not only for the
determination and understanding of the cardiovascular changes as a time course inflight
but will contribute to the operational medical
assessment of the Skylab crew as a function
of mission duration. This is considered to be
the earliest observable physiological system
to change in man since it was observed even
in the short duration of the Mercury missions.
However, the changes in the cardiovascular
system cannot be disassociated from blood
volume and body fluid changes.

In Sky lab, we will use the bicycle ergometer
and its supporting equipment inflight in the
same configuration as that used pre- and
postflight (Figure 11). Inflight, the ergometer will be used at 25, 50 and 75# of the
preflight control value. During this experiment, blood pressure, vectorcardiography and
metabolic rates will be obtained. This will
be the first attempt to obtain inflight data
on pulmonary function (minute volume and vital
capacity). In addition, this will provide
a significant increase in the level of
sophistication in our assessment of work
capacity during manned space flight.
NEUROFHYSIOLOGICAL FUNCTION - VESTIBULAR AND
SLEEP (Figure 12)
Although not reported by all the Apollo crewmen, many have indicated postflight that
early in the mission, they experienced what
has been commonly referred to as "stomach
awareness." This has usually disappeared
within the first ^8 hours of the mission with
no reoccurrence. Interestingly enough,
Mercury and Gemini were free of any reports
or instances of this nature including Gemini
5 and 7 where specific head movements were
programmed as an experiment to see if any of
the symptoms of motion sickness could be
induced. In Apollo, we have had, early in
the flight program, one or two instances that
could be termed "motion sickness." In Apollo
15, we had our one and only instance of a
postflight vestibular finding. One of the
crewmen experienced "stomach awareness" during
trans-lunar coast which disappeared with
lunar orbit and landing and did not reoccur
during trans-Earth coast. However, following
recovery, he experienced what was described
as a feeling of being about 20-30 degrees
head-down when lying horizontally in bed.
This condition completely disappeared after
about one week.

PULMONARY FUNCTION AND ENERGY METABOLISM
(Figure 10)

In the area of sleep, we have mainly subjective reporting wherein early in the Gemini
Program, the attempt to have one man awake
and on duty while the other one slept proved
to be disturbing to the one trying to sleep.
This culminated in the change to both crewmen sleeping at the same time to avoid the
noise and activity which occurred with one
crewman awake and active % In Gemini T» inflight electroencephalograms were obtained and
no abnormalities whatsoever' were found on the
returned records.

There has been, in most instances in Apollo,
a reduced work capacity postflight compared
to preflight values. This has usually
returned to preflight levels in two days and
is based on the oxygen consumption required
for a calibrated workload on a bicycle
ergometer. When it has occurred, it has
averaged a 25$ reduction from the preflight
level. It is interesting to note that the
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Postflight analyses of the returned films
will be compared to films of the same functions taken during preflight training and
simulation (Figure 1?)

In Sky lab, we will have our first opportunity
to investigate the question of whether there
is a threshold shift in sensitivity of the
vestibular apparatus in weightlessness. This
will be done by using a rotating chair, electrically driven, and so designed that all
rotations of the chair including starting and
stopping are below the threshold of perception in a 1-G environment (Figure 13) The
chair will be used in two modes: (l) in the
dynamic (rotating) mode which will assess the
sensitivity of the semi-circular canals in
the weightless environment; and (2) the static
mode which will assess the sensitivity of the
otoliths in the weightless environment.

jXPERIMENT INTERRELATIONSHIPS (Figure 18)

I am sure it has become evident that as I
have described these medical experiments that
they are interrelated and that the results
of one will have a bearing on another. For
example, if stomach awareness should occur
early in the Skylab mission as it has on the
Apollo flights, this would have an understandable effect on eating. If the intake
of food and fluid is reduced, then, there
will be a resultant effect on the nutritional
and electrolyte data. The electrolyte
changes can, in turn, effect fluid shifts
and fluid loss from the body which, in turn,
would be reflected in the cardiovascular
system changes. With changes in the cardiovascular system, it would be natural to
expect a change in exercise response and, of
course, nutrition is directly related to
energy metabolism. Any of these foregoing
features could influence the quality and
quantity of sleep which could result in
fatigue and could be reflected in performance changes. The point here is not that
any or all of these things will occur but
it establishes the fact that there is this
close interrelationship in all of these
experiments and not one of them stands alone
nor can it be evaluated without complete
knowledge of the results of the other. A
very important element of this Skylab Medical
Experiments Program is the fact that Medical
Experiment Principal Investigators are
working together as a team. The medical
evaluations and decisions will be based on
the integration by this team of the total
data analysis process. This insures that no
isolated data point will be misconstrued and
insures a cross-check which will preclude
erroneous judgment.

In addition to the above, EEG f s will be
obtained on one of the crewmen during sleep
about every other night (15 times in the 28
day SL-2 mission and 21 times in the $6 day
SL-3 and k mission) - (Figure 1*0 . This EEC
is designed with an automatic onboard analyzer and associated magnetic tapes for
storing and returning the data which will
permit the subsequent analyses of the amount
of each of the four stages of sleep. Some
of the fatigue which has been consistently
observed in the crewmen post flight might
possibly be associated with changes in sleep
quality. It is most important to keep in
mind that there is great individual variability both between individuals and in the same
individual in the vestibular and sleep areas.
TIME AM) MOTION - BEHAVIORAL (Figure 15)
If you recall in Figure 1, I listed this as
"Behavioral - Lunar Surface" since we have
observed no psychological or performance
changes in our manned space flight activities
to date. We have looked at data from many
flight activities such as rendezvous and
docking, lunar orbit insertion, LEM descent
and landing and other inflight activities and,
in each instance, the flight performance can
be superimposed upon the simulation and
training data with no significant differences.
The only area in which we have determined a
change has been in the translation of the
training and simulation for EVA from the 1-G
environment to the 1/6 G on the lunar surface.
Our studies have indicated that it has taken
longer in the 1/6 G than we had planned in
the timeline for many of the lunar surface
activities. We have also noted that there
is a rapid learning experience on the lunar
surface with shortening of the time required
for certain activities with each subsequent
EVA.

.SUMMARY

Virtually all of our medical information from
manned space flights to date has been derived
from pre- and post flight data or observations made by the crewmen and reported at
the postflight debriefings. Skylab presents
the first opportunity to investigate infligiht, the time course of the physiological
parameters of prime importance to manned
space flight.
The medical experiments in Skylab are unique
in that they are not only experiments but
will provide operational and medical informa^
tion for mission continuation decisions and
equally as important; the basis for the go/
no go decision for SL-3 after SL-2.

In Skylab, we will assess the translation of
1-G and water immersion training to the
actual inflight situation (Figure 16). We
will use the data acquisition camera to film
already scheduled activities, primarily experiments but some operational activities as well.
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It is only reasonable to expect that many new
questions will arise from the Slcylab Medical
Experiments Program. Conversely, it would
be overly optimistic to assume that we will
obtain answers to all the questions concerning
the observed changes we have seen in manned
space flights to date. However, the Skylab
Medical Experiments Program is a tremendous
stride forward in that direction* It will be
an important contribution to the future of
manned space flight.
AREAS OF MAJOR MEDICAL OBSERVATIONS
o

METABOLISM

o

H&4ATOLOGY

O

CARDIOVASCULAR

o

PULMONARY

o

VESTIBULAR

o

BEHAVIORAL - LUNAR SURFACE

Figure 1.
tions.

Waste Management System.

Figure k.

Areas of Major Medical Observa-

NUTRITIONAL AND MUSCULOSKELSTAL FUNCTION
(METABOLISM)
PURPOSE:

DETERMINE EXTENT OF SKELETAL AND MUSCULAR
ALTERATIONS; EVALUATE MINERAL, WATER,
ELECTROLYTE AND HORMONAL CHANGES; ASSESS
NUTRITIVE REQUIREMENTS

Figure 2.

Metabolism.
Body Mass Measurement Device.

Figure 5.

HllftTOLOGY' AID PJCTODOGY
PURPOSE.:

J2KPERMINS SPACE FUG1T EFFECTS ON
PHXSIDLOG? OF FORMED BLOOD ELEMENTS,
'BODY FUTQ) CGMPAKEMEKPS, AND'
SffilCTED ASPECT S OF IMMUNITY

Figure 3.

Figure 6.

Small Mass Measurement Device.
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Hematology and Immunology.

PULMONARY FUNCTION AND ENERGY METABOLISM

PURPOSE: ASSESS EFFECTS OF SPACECRAFT ENVIRONMENT ON
CREW'S RESPIRATION, BODY MASS AND COMPOSITION,
AND ENERGY COSTS OF PHYSICAL ACTIVITY

Figure 10. Pulmonary Function and Energy
Metabolism.

Figure ?

Automatic Sample Processor.

CARDIOVASCULAR FUNCTION

PURPOSE:

ASSESS EFFECTS OF SPACE FLIOTT
ON CIRCULATORY SYSTEM
(HEART AND BLOOD VESSELS)

Figure 8.

Cardiovascular Function.

Figure 11.
Analyzer.

*******

Bicycle Ergoineter and Metabolic

NEUROFHYSIOLOGECAL FUNCTION
(VESTIBULAR AND SLEEP)
PURPOSE:

EVALUATE EFFECTS OF THE SPACE
ENVIRONMENT UPON THE CENTRAL
NERVOUS SYSTEM OF MAI

Figure 12. Neurophysiological Function Vestibular and Sleep.

Lover Body Negative Pressure
Figure 9Device (LBNP).
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TIME AND MOTION
(BEHAVIORAL)
PURPOSE: ASSESS MAN'S FUNCTIONAL EFFICIENCY IN
COMPLETING OPERATIONAL AND SCIENTIFIC WORK
DURING LONG DURATION SPACE FLK3KT

Figure 15.

Figure 13.

Time and Motion - Behavioral.

Rotating Litter Chair.

Figure 16.

Figure Ik.

Sleep Station.

1-7

Orbital Workshop - Work Area.

TIME AND MOTION STUDY
SKYLAB EXPERIMENT MIS!
16 MM CAMERA WITH
QUICK UNIVERSAL
MOUNT

PORTABLE HIGH
INTENSITY
PHOTOGRAPHIC
LAMP

NASA HQ ML71-.
2-2-71

ACTIVITY TO BE PHOTOGRAPHED

Figure IT.

Time and Motion Hardware.

LIFE SCIENCES EXPERIMENT INTERRELATIONSHIPS
TIME AND MOTION STUDY

Sti.EP MONITORING
MINERAL BALANCE

^^'"^'^^
/

BONE DENSITOMETRY
BICASSAY OF 8CDY FLUIDS

^

CIMEN MASS MEASUREMENT /
SPECIME

X

METABOLIC ACTIVITY

PULMONARY
AND
ENERGY
METABOLISM

CYTCGENETIC STUDIES
OF BLOOD

BODY MASS MEASUREMENT

MAN'S IMMUNITY IN
VITRO ASPECTS
BLOOD VOLUME AND RED CELL
LIFE SPAN

LOWER BODY NEGATIVE PRESSURE
(PRE- & POST-FLIGHT;

RED BLOOD CELL METABOLISM
INFLIGHT LOWER BODY
NEGATIVE PRESSURE

SPECIAL HEMATCLCGlC EFFECT
SINGLE HUMAN CELL

VECTORCARDIOGRAM

HABITABILITY

ENVIRONMENT

BIO-RHYTHMS

HABITABILITY,CREW QUARURS

AEROSOL ANALYSIS

ORCADIAN RHYTHM - POCKET MICE

RADIATION MONITORING

Figure 18.
ships .

ORCADIAN RHYTHM - VINEGAR GNAT

Medical Experiments Interrelation
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